The Sanford Guide to Antimicrobial Therapy Spiral Bound Edition

The classic pocket reference in print is in its 44th edition for 2014. Content is organized in tables that cover all aspects of treatment plus comprehensive anti-infective drug information and many useful tools. Recommendations are evidence-based and extensively referenced. Generations of physicians have relied on this edition to help them make informed treatment decisions at the point of care. The content has been updated to reflect current best-evidence recommendations for treatment of bacterial, fungal, mycobacterial, parasitic and viral infections, newly approved drugs, new indications for existing drugs and references to new reports in the literature. Contents ABBREVIATIONS TABLE 1 Clinical Approach to Initial Choice of Antimicrobial Therapy TABLE 2 Recommended Antimicrobial Agents Against Selected Bacteria TABLE 3 Suggested Duration of Antibiotic Therapy in Immunocompetent Patients TABLE 4 Comparison of Antibacterial Spectra TABLE 5A Treatment Options For Systemic Infection Due To Multi-Drug Resistant Gram-Positive Bacteria TABLE 5B Treatment Options for Systemic Infection Due to Selected Multi-Drug Resistant Gram-Negative Bacilli TABLE 6 Suggested Management of Suspected or Culture-Positive Community-Associated Methicillin-Resistant S. aureus Infections TABLE 7 Drug Desensitization methods TABLE 8 Risk Categories of Antimicrobics in Pregnancy TABLE 9A Selected Pharmacologic Features of Antimicrobial Agents TABLE 9B Pharmacodynamics of Antibacterials TABLE 9C Enzyme -and Transporter- Mediated Interactions of Antimicrobials TABLE 10A Antibiotic Dosage and Side-Effects TABLE 10B Selected Antibacterial Agents—Adverse Reactions—Overview TABLE 10C Antimicrobial Agents Associated with Photosensitivity TABLE 10D Aminoglycoside Once-Daily and Multiple Daily Dosing Regimens TABLE 10E Prolonged or Continuous Infusion Dosing of Selected Beta Lactams TABLE 10F Inhalation Antibiotics TABLE 11A Treatment of Fungal Infections—Antimicrobial Agents of Choice TABLE 11B Antifungal Drugs: Dosage, Adverse Effects, Comments TABLE 11C At A Glance Summary of Suggested Antifungal Drugs Against Treatable Pathogenic Fungi TABLE 12A Treatment of Mycobacterial Infections TABLE 12B Dosage and Adverse Effects of Antimycobacterial Drugs TABLE 13A Treatment of Parasitic Infections TABLE 13B Dosage and Selected Adverse Effects of Antiparasitic Drugs TABLE 13C Parasites that Cause Eosinophilia (Eosinophilia In Travelers) TABLE 13D Sources for Hard-to-Find Antiparasitic Drugs TABLE 14A Antiviral Therapy TABLE 14B Antiviral Drugs (Non-HIV) TABLE 14C At A Glance Summary of Suggested Antiviral Agents Against Treatable Pathogenic Viruses TABLE 14D Antiretroviral Therapy (ART) in Treatment-Naïve Adults (HIV/AIDS) TABLE 14E Antiretroviral Drugs and Adverse Effects TABLE 14F Hepatitis A & HBV Treatment TABLE 14G HCV Treatment Regimens and Response TABLE 15A Antimicrobial Prophylaxis for Selected Bacterial Infections TABLE 15B Antibiotic Prophylaxis to Prevent Surgical Infections in Adults TABLE 15C Antimicrobial Prophylaxis for the Prevention of Bacterial Endocarditis in Patients with Underlying Cardiac Conditions TABLE 15D Management of Exposure to HIV-1 and Hepatitis B and C TABLE 15E Prevention of Selected Opportunistic Infections in Human Hematopoietic Cell Transplantation (HCT) or Solid Organ Transplantation (SOT) in Adults With Normal Renal Function TABLE 16 Pediatric Dosages of Selected Antibacterial Agents TABLE 17A Dosages of Antimicrobial Drugs in Adult Patients with Renal Impairment TABLE 17B No Dosage Adjustment with Renal Insufficiency by Category TABLE 17C Antimicrobial Dosing in Obesity TABLE 18 Antimicrobials and Hepatic Disease: Dosage Adjustment TABLE 19 Treatment of CAPD Peritonitis in Adults TABLE 20A Anti-Tetanus Prophylaxis, Wound Classification, Immunization TABLE 20B Rabies Postexposure Prophylaxis TABLE 21 Selected Directory of Resources TABLE 22A Anti-Infective Drug-Drug Interactions TABLE 22B Drug-Drug Interactions Between Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) and Protease Inhibitors TABLE 23 List of Generic and Common Trade Names INDEX OF MAJOR ENTITIES